{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:11:58Z","timestamp":1758190318698,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020643","name":"Medical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.rcsop.2025.100614","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T17:58:50Z","timestamp":1747591130000},"page":"100614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of mRNA COVID-19 vaccination on hematological parameters in patients maintained on clozapine: A retrospective study from Qatar"],"prefix":"10.1016","volume":"19","author":[{"given":"Dalia","family":"Albahari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oraib","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatha Mahmud Ismail","family":"Alqam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Faisal Hamad","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ali Siddig","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovais","family":"Wadoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rcsop.2025.100614_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.rcsop.2025.100614_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100614_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqab016","article-title":"Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology","volume":"2","author":"Codd","year":"2021","journal-title":"Oxf Open Immunol"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100614_bb0020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2174\/1570159X22666231128101725","article-title":"Immunomodulatory effects of clozapine: more than just a side effect in schizophrenia","volume":"22","author":"Amerio","year":"2024","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.rcsop.2025.100614_bb0025","article-title":"Immune system abnormalities in schizophrenia: an integrative view and translational perspectives","volume":"13","author":"Ermakov","year":"2022","journal-title":"Front Psych"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100614_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","author":"Najjar","year":"2015","journal-title":"Schizophr Res"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100614_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/acps.13443","article-title":"Haematological changes and adverse events associated with BNT162b2 mRNA COVID-19 vaccine in patients receiving clozapine-findings from an audit","volume":"146","author":"Lim","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rcsop.2025.100614_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102658","article-title":"Clozapine prescribing and safety during COVID-19","volume":"60","author":"Wadoo","year":"2021","journal-title":"Asian J Psychiatr"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100614_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2617","article-title":"Clozapine prescribing practice and trends in Qatar: first national observational study","volume":"12","author":"Wadoo","year":"2022","journal-title":"Brain Behav"},{"year":"2024","series-title":"Clozapine Prescribing Information","author":"FDA","key":"10.1016\/j.rcsop.2025.100614_bb0050"},{"year":"2013","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.rcsop.2025.100614_bb0055"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100614_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/a-1562-2521","article-title":"COVID-19: risks, complications, and monitoring in patients on clozapine","volume":"55","author":"Veerman","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.rcsop.2025.100614_bb0065","doi-asserted-by":"crossref","unstructured":"Aksar A, Lutz J, Wagner E, Strube W, Luykx JJ, Hasan A. Vaccination and clozapine use: a systematic review and an analysis of the VAERS database. Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):141-162. doi: 10.1007\/s00406-023-01729-0. Epub 2024 Jan 2. PMID: 38165458.","DOI":"10.1007\/s00406-023-01729-0"},{"key":"10.1016\/j.rcsop.2025.100614_bb0070","article-title":"COVID-19 mRNA vaccines are generally safe in the short term: a vaccine vigilance real-world study says","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rcsop.2025.100614_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103129","article-title":"Psychiatric adverse reactions to COVID-19 vaccines: a rapid review of published case reports","volume":"71","author":"Balasubramanian","year":"2022","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"10.1016\/j.rcsop.2025.100614_bb0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ajh.26478","article-title":"COVID-19 vaccines and risks of hematological abnormalities: nested case-control and self-controlled case series study","volume":"97","author":"Sing","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rcsop.2025.100614_bb0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/JCP.0000000000001527","article-title":"A decrease of neutrophils after COVID-19 vaccination in a treatment-resistant patient with schizophrenia taking clozapine","volume":"42","author":"Takaki","year":"2022","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rcsop.2025.100614_bb0090","doi-asserted-by":"crossref","unstructured":"Tomita T, Sakamoto Y, Saito M, Hashimoto K, Ono Y, Nakamura K. Two Patients with Schizophrenia Treated with Clozapine Developed Neutropenia After Receiving a COVID-19 Vaccine. Int Med Case Rep J. 2022 Jan 28;15:29-33. doi: 10.2147\/IMCRJ.S350879. PMID: 35115846; PMCID: PMC8805838.","DOI":"10.2147\/IMCRJ.S350879"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100614_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/schbul\/sbac148","article-title":"Clozapine therapy and COVID-19: a systematic review of the prevalence rates, health outcomes, hematological markers, and patient perspectives","volume":"49","author":"Giles","year":"2023","journal-title":"Schizophr Bull"},{"issue":"9","key":"10.1016\/j.rcsop.2025.100614_bb0100","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100614_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-1-8","article-title":"Polymorphism in clinical immunology - from HLA typing to immunogenetic profiling","volume":"1","author":"Jin","year":"2003","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.rcsop.2025.100614_bb0110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/14760584.2015.1038249","article-title":"Adversomics: a new paradigm for vaccine safety and design","volume":"14","author":"Whitaker","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.rcsop.2025.100614_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/lc.1999.v133.a94931","article-title":"Benign ethnic neutropenia: what is a normal absolute neutrophil count?","volume":"133","author":"Haddy","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.rcsop.2025.100614_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.06.003","article-title":"Benign ethnic neutropenia","volume":"37","author":"Atallah-Yunes","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.rcsop.2025.100614_bb0125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41397-021-00231-x","article-title":"Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients","volume":"21","author":"Ammar","year":"2021","journal-title":"Pharmacogenomics J"},{"issue":"S1","key":"10.1016\/j.rcsop.2025.100614_bb0130","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.375","article-title":"Ethnic differences in dose and levels of clozapine: exploring need for any specific monitoring needs","volume":"9","author":"Jiwanmall","year":"2023","journal-title":"BJPsych Open"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100614_bb0135","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J Invest Med"},{"issue":"2","key":"10.1016\/j.rcsop.2025.100614_bb0140","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0029665112000092","article-title":"Obesity, inflammation and the immune system","volume":"71","author":"de Heredia","year":"2012","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.rcsop.2025.100614_bb0145","first-page":"16","article-title":"COVID-19 disease outcomes in patients receiving clozapine versus other antipsychotics: a national study in Qatar","volume":"16","author":"Albahari","year":"2025","journal-title":"Front Psych"},{"issue":"6","key":"10.1016\/j.rcsop.2025.100614_bb0150","article-title":"Mental health during COVID-19 in Qatar","volume":"33","author":"Wadoo","year":"2020","journal-title":"Gen Psychiatr"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:32:46Z","timestamp":1758083566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276625000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S2667276625000551"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100614","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of mRNA COVID-19 vaccination on hematological parameters in patients maintained on clozapine: A retrospective study from Qatar","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100614"}}